These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 2952794
1. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin. Tumiati B, Veneziani M, Bellelli A, Portioli I. J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794 [No Abstract] [Full Text] [Related]
2. [Chrysotherapy and side effects (author's transl)]. Eberl R. Wien Klin Wochenschr Suppl; 1974 Feb; 25():3-22. PubMed ID: 4279096 [No Abstract] [Full Text] [Related]
3. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. Klinefelter. J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042 [Abstract] [Full Text] [Related]
4. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate. Svensson A, Theander J. Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505 [Abstract] [Full Text] [Related]
5. Skin testing with gold sodium thiomalate and gold sodium thiosulfate. Bruze M, Björkner B, Möller H. Contact Dermatitis; 1995 Jan; 32(1):5-8. PubMed ID: 7720377 [Abstract] [Full Text] [Related]
6. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety]. Batlle Gualda E. Med Clin (Barc); 1985 Jun 08; 85(2):73-9. PubMed ID: 3160899 [No Abstract] [Full Text] [Related]
8. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin]. Yamamoto S, Mitomo N, Saito T, Nishioka K, Inoue K, Uchida S, Ohata N, Murasawa A, Suzuki A, Mitsui T. Ryumachi; 1990 Feb 05; 30(1):26-44. PubMed ID: 2116042 [Abstract] [Full Text] [Related]
9. [Gold preparations in therapy of rheumatoid and psoriatic arthritis]. Nasonova VA, Lukina GV, Sigidin IaA, Badokin VV. Ter Arkh; 2003 Feb 05; 75(5):88-90. PubMed ID: 12847908 [No Abstract] [Full Text] [Related]
10. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate. Rodriguez-Pérez M, González-Dominguez J, Matarán L, Garcia-Pérez S, Salvatierra D. J Rheumatol; 1994 Jan 05; 21(1):41-3. PubMed ID: 8151585 [Abstract] [Full Text] [Related]
12. Injectable gold dermatitis and proteinuria: retreatment with auranofin. Tosi S, Cagnoli M, Guidi G, Murelli M, Messina K, Colombo B. Int J Clin Pharmacol Res; 1985 Jan 05; 5(4):265-8. PubMed ID: 2932399 [Abstract] [Full Text] [Related]
13. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K. J Rheumatol Suppl; 1982 Jan 05; 8():197-200. PubMed ID: 6813485 [Abstract] [Full Text] [Related]
14. Scarring alopecia following gold therapy. Burrows NP, Grant JW, Crisp AJ, Roberts SO. Acta Derm Venereol; 1994 Nov 05; 74(6):486. PubMed ID: 7701895 [No Abstract] [Full Text] [Related]
15. Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats. Finkelstein AE, Ladizesky M, Borinsky R, Kohn E, Ginsburg I. Inflammation; 1988 Aug 05; 12(4):373-82. PubMed ID: 3139562 [Abstract] [Full Text] [Related]
16. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis. Wessel J, Davis P. J Rheumatol; 1983 Aug 05; 10(4):664. PubMed ID: 6413690 [No Abstract] [Full Text] [Related]
18. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study. Harth M, Davis P, Thompson JM, Menard H, Beaudet F. Scand J Rheumatol; 1987 Aug 05; 16(3):177-84. PubMed ID: 3110944 [Abstract] [Full Text] [Related]